Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)

Clinical trial NCT03775096 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03775096
Sponsor: Michele Tagliati, MD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

REM Sleep Behavior Disorder Pre-motor Parkinson Disease Symptomatic Parkinson Disease

Start date: 2019-04-04
Primary completion: 2026-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.